USFDA Med Dev Guidance: Applying Human Factors and Usability Engineering

As medical devices become increasingly sophisticated, ensuring that they are safe and intuitive to use is just as important as demonstrating their technical performance. Many device-related incidents are not caused by product failure but by use errors that arise from complex interfaces, confusing instructions, or challenging use environments.

The U.S. Food and Drug Administration (FDA) has updated the guidance Applying Human Factors and Usability Engineering to Medical Devices to help manufacturers integrate human factors engineering (HFE) and usability engineering (UE) throughout the medical device development process. The guidance provides a risk-based framework for identifying, evaluating, and mitigating use-related hazards to improve device safety and effectiveness.

Why This Guidance Is Important

Medical devices are used by a wide range of individuals, including healthcare professionals, patients, caregivers, and maintenance personnel, across diverse healthcare settings. Differences in user experience, training, physical abilities, and environmental conditions can significantly influence device performance and patient safety.

This guidance encourages manufacturers to incorporate human factors and usability engineering early in device development to identify potential use errors, reduce use-related risks, and ensure that devices can be used safely and effectively under real-world conditions.

Human Factors as Part of Risk Management

FDA recommends integrating human factors engineering into the overall risk management process rather than treating it as a standalone activity.

Manufacturers should identify potential use-related hazards, evaluate how users interact with the device, implement appropriate risk control measures, and verify that these controls effectively minimize the likelihood of use errors. This proactive approach helps reduce hazards before devices reach the market and supports the development of safer products.

Understanding Users, Use Environments, and User Interfaces

Successful device design begins with understanding who will use the device, where it will be used, and how users will interact with it.

Manufacturers should evaluate the characteristics of intended users, including their physical, sensory, cognitive, and educational capabilities. Consideration should also be given to the environments in which devices are used, such as hospitals, emergency settings, clinics, or home care environments, where factors like lighting, noise, distractions, and workflow may influence device operation.

The guidance also emphasizes optimizing the user interface—including controls, displays, alarms, packaging, labeling, and instructions for use—to support intuitive operation and minimize the risk of user error.

Identifying and Reducing Use-Related Hazards

FDA recommends performing systematic analyses early in development to identify critical tasks and potential use-related hazards.

Manufacturers are encouraged to use methods such as task analysis, failure mode and effects analysis (FMEA), fault tree analysis (FTA), expert reviews, user interviews, and formative evaluations to understand how users interact with devices and where errors may occur. Findings from these evaluations should guide design improvements, refine user interfaces, and strengthen risk control strategies before final validation.

Where possible, hazards should be eliminated through design modifications rather than relying solely on labeling or user training.

Human Factors Validation Testing

Before marketing a medical device, manufacturers should conduct human factors validation testing to demonstrate that intended users can safely and effectively operate the final device under realistic conditions.

Validation testing should include representative users performing critical tasks using the final device design in simulated or actual use environments. Testing should assess whether any use errors remain that could result in serious harm and evaluate the effectiveness of implemented risk control measures.

FDA also encourages manufacturers to engage with the Agency during development, particularly when planning human factors validation studies, to help ensure that proposed testing approaches adequately support regulatory submissions.

By understanding user needs, improving device interfaces, and systematically addressing use-related risks, manufacturers can enhance patient safety, strengthen regulatory submissions, and deliver medical devices that perform reliably in real-world clinical practice.

References

• Guidance for Industry and Food and Drug Administration Staff: Applying Human Factors and Usability Engineering to Medical Devices (August 2026).